DFW Capital Partners Closes Investment in Lotus Clinical Research, LLC

DFW Capital Partners (“DFW”) announced that it has formed Continuum Research Group (“CRG”) and that CRG has completed its first investment in Lotus Clinical Research, LLC of Pasadena, California (“Lotus” or the “Company”). CRG is led by Jeffrey Kinell, who previously was the CEO of Bracket Global, a leader in clinical trials technology , and… Read more »

DFW Capital Partners successfully exits its investment in Fleetwash

DFW Capital Partners announced today that it has completed the sale of its portfolio company, Fleetwash Holdings, Inc., to an affiliate of ACON Investments. The sale represents the fifth sale or major liquidity event for the firm’s 2012 vintage fund, DFW Capital Partners IV, LP. DFW led the recapitalization of New Jersey-based Fleetwash in 2014,… Read more »

DFW Capital Partners Closes Investment in Restoration + Recovery

DFW Capital Partners (“DFW”) announced today that it has completed a growth investment in Restoration + Recovery, a leading provider of post-construction stormwater management services, including inspection, maintenance, repair, consulting services and emergency response, based in Durham, NC. The company’s experience, approach, scope of services and geography enable it to provide high level stormwater management… Read more »

DFW Capital Partners Successfully Exits its Investment in Evolution Research Group

DFW Capital Partners (“DFW”) is pleased to announce that it has completed the sale of its portfolio company, Evolution Research Group (“ERG”), to Linden Capital Partners. ERG is comprised of ten wholly-owned and operated clinical research units, Thievon-Wright Consulting Group (“TWCG”) and an established network of affiliated clinical research sites. ERG conducts a wide range… Read more »

DFW Portfolio Company, Sebela Pharmaceuticals, Acquires Braintree Laboratories

DFW Capital Partners (“DFW”) announced today that its portfolio company, Sebela Pharmaceuticals (“Sebela”), has completed the acquisition of Braintree Laboratories Inc., (“Braintree”), a privately held specialty pharmaceutical company based in Boston, Massachusetts. Braintree develops, manufactures and markets specialty pharmaceuticals in gastroenterology. Braintree’s market-leading colonoscopy prep franchise includes SUPREP™, the #1 prescribed colon prep since 2013.… Read more »

DFW Capital Partners closes investment in ReSource Pro

DFW Capital Partners (“DFW”) announced today that it has completed an investment in ReSource Pro Holdings, LLC (“ReSource Pro” or the “Company”). ReSource Pro is the leader in providing strategic business process management and outsourcing to the insurance industry – focusing on delivering dedicated back-office and business analytics support to insurance agencies, managing general agents,… Read more »

DFW Capital Partners Closes Strategic Investment in INSIGHT2PROFIT

DFW Capital Partners (“DFW”) is pleased to announce that it recently completed a strategic investment in INSIGHT2PROFIT. INSIGHT2PROFIT is a fast growing technology-enabled service company focused on delivering sustainable revenue and EBITDA growth through implementation and management of pricing and profit strategies. INSIGHT2PROFIT has locations in Cleveland, Ohio and Chicago, Illinois. “We are excited about… Read more »